Latest Breaking News On - University hospital hamburg eppendorf - Page 8 : vimarsana.com

Published: May 10, 2021 ( Copenhagen, May 10, 2021). ZERION Pharma, a Danish pharmaceutical company, elected two new members Dr. Torsten Goesch and Dr. Lars Lykke Thomsen to join its board of directors at the annual general meeting held on May 6, 2021. Dr. Torsten Goesch is an experienced life science venture capital investor and has been a partner and director at Rosetta Capital since 2002. Dr. Goesch is also the founder and former managing director of TRG invest, a Munich-based consultancy serving companies in the life science sector. Prior to his role at Rosetta capital he was the general manager of Biogen in Europe from 1997 to 1999 and before this he was the commercial head of Merck KGaA’s generic drug business, Merck Generics. He brings a wealth of experience to the role, having served on the board of many notable biopharmaceutical companies including Enobia Ltd, Cytochroma Ltd and the Danish company Forward Pharma. Dr. Goesch is a physician by training and holds an

Nordrhein westfalenTorsten goeschLars lykke thomsenUniversity of copenhagenUniversity hospital hamburgUniversity of aalborgHeinrich heine university dusseldorfCytochroma ltdMerck kgaMerck kgaaEnobia ltdRosetta capitalHeinrich heine universityUniversity hospital hamburg eppendorfGraduate schoolChief medical officer